OGI
Organigram Global Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.16
−1.28%Forward multiples
Based on analyst estimates
- P/E forward
- 46.59x
- P/E 2026E
- 3.42x
- P/E 2027E
- 52.53x
- P/E 2028E
- 23.63x
- P/S forward
- 0.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.52x
- PEG TTM
- —
- Price / book
- 0.41x
- Price / sales
- 0.74x
- Price / cash flow
- -8.05x
Enterprise value
- Enterprise value
- $224.8M
- EV / sales
- 1.00x
- EV / EBITDA
- 16.25x
- EV / EBIT
- -46.32x
- Market cap
- $166.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026